Microtubule-associated protein Tau (MAPT) overexpression has been linked to poor prognosis and decreased response to taxane-based therapies in several cancer types, but its relevance in prostate cancer is unknown. | Aberrant expression of the microtubuleassociated protein tau is an independent prognostic feature in prostate cancer